南美和中美阿片类药物市场预测至 2030 年 - 区域分析 - 按产品（速释短效阿片类药物和缓释长效阿片类药物）、应用（疼痛管理、麻醉、腹泻抑制、咳嗽抑制、脱瘾等）、给药途径（口服、注射和透皮贴剂）和分销渠道（医院药房和零售药房）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 74    |    Report Code: BMIRE00031031    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Opioids Market
Free Sample Buy Now
2022 年，南美和中美洲阿片类药物市场价值为 4.7828 亿美元，预计到 2030 年将达到 5.8407 亿美元；预计 2022 年至 2030 年的复合年增长率为 2.5%。

老年人口增加推动南美和中美洲阿片类药物市场发展

大多数老年人患有慢性疼痛，导致日常活动能力下降。老年人口普遍患有骨关节疾病、关节炎、癌症和其他引起疼痛的慢性疾病。根据世界卫生组织 (WHO) 2018 年 2 月的数据，到 2050 年老年人口预计将增长 22%，而 2015 年为 12%。数据还表明，中低收入国家将占这一增长的近 80%。得益于医疗设施的改善和医疗服务的改善，一些发达国家的老年人口也出现了显著增长，从而提高了这些地区的预期寿命。人口老龄化主要通过增加对疼痛管理解决方案的需求来推动阿片类药物市场的发展。此外，老年人经常接受需要疼痛管理的手术和医疗程序。因此，该地区老年人口的不断增长推动了阿片类药物市场的增长。

南美和中美阿片类药物市场概况

根据泛美卫生组织 (PAHO) 的数据，巴西有超过 3000 万人年龄在 60 岁及以上，占该国人口的 13%。到 2030 年，这一数字预计将达到约 5000 万，占巴西人口的 24%。根据巴西地理统计局的数据，到 2050 年，该国 65 岁及以上人口预计将占巴西总人口的 36%。慢性疼痛是影响老年人的最常见疾病之一。患有这种疾病的人更喜欢使用阿片类药物，导致阿片类药物处方增加。

根据巴西卫生监管机构 (ANVISA) 和巴西私立医院系统的数据，巴西受到 COVID-19 大流行的严重影响，截至 2022 年 4 月，已有 700,000 人死亡。根据巴西卫生监管机构 (ANVISA) 和巴西私立医院系统的数据，由于疫苗供应延迟，巴西公民的健康状况恶化，导致重症病例住院和呼吸机使用率高，这加速了对芬太尼的需求，芬太尼用于插管期间的镇静剂。

此外，根据 2023 年 4 月《柳叶刀区域卫生-美洲》上发表的数据，过去二十年，巴西的处方阿片类药物使用量有所增加，包括用于医疗和非医疗目的，这推动了巴西市场的发展。

南美洲和中美洲阿片类药物市场收入和预测到 2030 年（百万美元）

南美洲和中美洲阿片类药物市场细分

南美洲和中美洲阿片类药物市场分为产品、应用、给药途径、分销渠道和国家。

基于产品，南美洲和中美洲阿片类药物市场分为速释短效阿片类药物和缓释长效阿片类药物。速释短效阿片类药物在 2022 年占据了更大的市场份额。速释短效阿片类药物进一步细分为羟可酮、氢可酮、曲马多、可待因、丙氧芬等。缓释长效阿片类药物进一步细分为羟可酮、芬太尼、吗啡、美沙酮等。

就应用而言，南美和中美洲阿片类药物市场分为疼痛管理、麻醉、腹泻抑制、咳嗽抑制、戒毒等。疼痛管理部门在 2022 年占据了最大的市场份额。

按给药途径，南美和中美洲阿片类药物市场细分为口服、注射和透皮贴剂。口服药物在 2022 年占据了最大的市场份额。

按分销渠道划分，南美和中美阿片类药物市场分为医院药房和零售药房。2022 年，医院药房部分占据了更大的市场份额。

按国家划分，南美和中美阿片类药物市场分为巴西、阿根廷和拉丁美洲其他地区。2022 年，巴西占据了南美和中美阿片类药物市场份额的主导地位。

Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Rusan Pharma Ltd 和 Teva Pharmaceutical Industries Ltd 是南美和中美阿片类药物市场的一些领先公司。

South & Central America Opioids Strategic Insights

Strategic insights for South & Central America Opioids involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-opioids-market-strategic-framework.webp
Get more information on this report

South & Central America Opioids Report Scope

Report Attribute Details
Market size in 2022 US$ 478.28 Million
Market Size by 2030 US$ 584.07 Million
Global CAGR (2022 - 2030) 2.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 速释短效阿片类药物
  • 缓释长效阿片类药物
By 应用
  • 疼痛管理
  • 麻醉
  • 止泻
  • 止咳
  • 戒毒
By 给药途径
  • 口服
  • 注射
  • 透皮贴剂
By 分销渠道
  • 医院药房
  • 零售药房
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Endo International plc
  • Mallinckrodt Plc
  • Neuraxpharm Pharmaceuticals SL
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd
    		•
    Get more information on this report

    South & Central America Opioids Regional Insights

    The regional scope of South & Central America Opioids refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-opioids-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - South & Central America Opioids Market

    1. Endo International plc
    2. Mallinckrodt Plc
    3. Neuraxpharm Pharmaceuticals SL
    4. Rusan Pharma Ltd
    5. Teva Pharmaceutical Industries Ltd
    Frequently Asked Questions
    How big is the South & Central America Opioids Market?

    The South & Central America Opioids Market is valued at US$ 478.28 Million in 2022, it is projected to reach US$ 584.07 Million by 2030.

    What is the CAGR for South & Central America Opioids Market by (2022 - 2030)?

    As per our report South & Central America Opioids Market, the market size is valued at US$ 478.28 Million in 2022, projecting it to reach US$ 584.07 Million by 2030. This translates to a CAGR of approximately 2.5% during the forecast period.

    What segments are covered in this report?

    The South & Central America Opioids Market report typically cover these key segments-

  • 产品 (速释短效阿片类药物, 缓释长效阿片类药物)
  • 应用 (疼痛管理, 麻醉, 止泻, 止咳, 戒毒)
  • 给药途径 (口服, 注射, 透皮贴剂)

    • What is the historic period, base year, and forecast period taken for South & Central America Opioids Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Opioids Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in South & Central America Opioids Market?

    The South & Central America Opioids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Endo International plc
  • Mallinckrodt Plc
  • Neuraxpharm Pharmaceuticals SL
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd
    • Who should buy this report?

    The South & Central America Opioids Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Opioids Market value chain can benefit from the information contained in a comprehensive market report.

    south-and-central-america-opioids-market